Home > > > > > Report Detail

Graves Disease - Epidemiology Forecast to 2028

Publisher Name :
Date: 15-Jan-2019
No. of pages: 50
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Graves Disease - Epidemiology Forecast, 2028" report provides a comprehensive analysis of the Graves Disease epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered

- United States

- EU5 (Germany, France, Italy, Spain, and the United Kingdom)

- Japan

Study Period: 2016-2028

Graves Disease Epidemiology

The epidemiology section covers the historical, current as well as forecasted epidemiology for Graves Disease in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders' views are also taken into account to provide a deep understanding of the Graves Disease outlook. It also includes the explanation of changing trends of epidemiology outlining the Graves Disease scenario.

Graves Disease Epidemiology Segmentation

The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Graves Disease thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope

- The report covers detailed overview of Graves Disease explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns

- It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan

- The Graves Disease Report assesses the disease risk and burden and highlights the unmet needs

- It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths

- 10 Year Forecast

- 7MM Coverage

- Total Cases in Graves Disease

Key assessments

- Patient Segmentation in Graves Disease

- Graves Disease Risk & Burden

- Factors driving growth in a specific Graves Disease patient population

Graves Disease - Epidemiology Forecast to 2028

Table of Contents

1. Report Introduction
2. Graves Disease Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Graves Disease in 2016
2.2. Patient Share Distribution of Graves Disease in 2028
3. Disease Background and Overview: Graves Disease
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Graves Disease in 7MM
4.3. Total Prevalent/ Incident Patient Population of Graves Disease in 7MM - By Countries
5. Epidemiology of Graves Disease by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Graves Disease
5.1.3. Sub-Type Specific cases of the Graves Disease *
5.1.4. Sex- Specific Cases of the Graves Disease *
5.1.5. Diagnosed Cases of the Graves Disease
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Graves Disease
5.4.3. Sub-Type Specific cases of the Graves Disease *
5.4.4. Sex- Specific Cases of the Graves Disease *
5.4.5. Diagnosed Cases of the Graves Disease
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Graves Disease
5.5.3. Sub-Type Specific cases of the Graves Disease *
5.5.4. Sex- Specific Cases of the Graves Disease *
5.5.5. Diagnosed Cases of the Graves Disease
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Graves Disease
5.6.3. Sub-Type Specific cases of the Graves Disease *
5.6.4. Sex- Specific Cases of the Graves Disease *
5.6.5. Diagnosed Cases of the Graves Disease
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Graves Disease
5.7.3. Sub-Type Specific cases of the Graves Disease *
5.7.4. Sex- Specific Cases of the Graves Disease *
5.7.5. Diagnosed Cases of the Graves Disease
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Graves Disease
5.8.3. Sub-Type Specific cases of the Graves Disease *
5.8.4. Sex- Specific Cases of the Graves Disease *
5.8.5. Diagnosed Cases of the Graves Disease
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Graves Disease
5.9.3. Sub-Type Specific cases of the Graves Disease *
5.9.4. Sex- Specific Cases of the Graves Disease *
5.9.5. Diagnosed Cases of the Graves Disease
6. Unmet Needs of the Graves Disease
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

List of Tables

Table 1: Total Prevalent/Incident Cases of the Graves Disease in 7MM
Table 2: Total Prevalent/Incident Cases of the Graves Disease in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Graves Disease in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Graves Disease in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Graves Disease in United States (2016-2028)*
Table 6: Diagnosed Cases of the Graves Disease in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Graves Disease in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Graves Disease in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Graves Disease in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Graves Disease in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Graves Disease in France (2016-2028)
Table 12: Sub-Type Specific cases of the Graves Disease in France (2016-2028) *
Table 13: Sex- Specific Cases of the Graves Disease in France (2016-2028) *
Table 14: Diagnosed Cases of the Graves Disease in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Graves Disease in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Graves Disease in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Graves Disease in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Graves Disease in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Graves Disease in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Graves Disease in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Graves Disease in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Graves Disease in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Graves Disease in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Graves Disease in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Graves Disease in UK (2016-2028) *
Table 26: Diagnosed Cases of the Graves Disease in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Graves Disease in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Graves Disease in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Graves Disease in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Graves Disease in Japan (2016-2028)

List of Figures

Figure 1: Total Prevalent/Incident Cases of the Graves Disease in 7MM
Figure 2: Total Prevalent/Incident Cases of the Graves Disease in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Graves Disease in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Graves Disease in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Graves Disease in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Graves Disease in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Graves Disease in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Graves Disease in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Graves Disease in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Graves Disease in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Graves Disease in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Graves Disease in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Graves Disease in France (2016-2028) *
Figure 14: Diagnosed Cases of the Graves Disease in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Graves Disease in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Graves Disease in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Graves Disease in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Graves Disease in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Graves Disease in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Graves Disease in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Graves Disease in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Graves Disease in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Graves Disease in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Graves Disease in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Graves Disease in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Graves Disease in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Graves Disease in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Graves Disease in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Graves Disease in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Graves Disease in Japan (2016-2028)

  • Global Systemic Lupus Erythematosus (Sle) Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Nov-2023        Price: US 3380 Onwards        Pages: 109
    Market Overview of Global Systemic Lupus Erythematosus (Sle) Drugs market: According to our latest research, the global Systemic Lupus Erythematosus (Sle) Drugs market looks promising in the next 5 years. As of 2022, the global Systemic Lupus Erythematosus (Sle) Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents......
  • Autoimmune Drugs Industry Forecasts - China Focus
    Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 78
    This study focuses on China's Autoimmune Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and services. Th......
  • Autoimmune Drugs Companies in China
    Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 71
    This study focuses on China's Autoimmune Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of......
  • Autoimmune Drugs Markets in China
    Published: 27-Nov-2023        Price: US 4000 Onwards        Pages: 201
    China's demand for Autoimmune Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, indu......
  • Autoimmune Collaboration and Licensing Deals 2016-2023
    Published: 01-Oct-2023        Price: US 3995 Onwards        Pages: 450
    Autoimmune Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the autoimmune deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of autoimmune deals from 2016 to 2023. The report includes coverage of the following autoimmune diseases: Multiple sclerosis, Restless leg syndrome, Dermatitis, Eczema, Alopecia, Psoriasis, Celiac disease, Infla......
  • Global Autoimmune Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 29-Aug-2023        Price: US 3380 Onwards        Pages: 101
    Market Overview of Global Autoimmune Drugs market: According to our latest research, the global Autoimmune Drugs market looks promising in the next 5 years. As of 2022, the global Autoimmune Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Autoimmune Drugs market......
  • Global Autoimmune Drugs Market Insights, Forecast to 2029
    Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 92
    Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ functions. Immunological complications due to physiological processes within the human body lead to autoimmune diseases. These diseases are characterized by chronic inflammatory processes that activate the innate immune system and the production of antibodies that destroy host tissues. These inflammatory processes can be caused by genetic or environmental ......
  • Global Systemic Lupus Erythematosus (SLE) Drugs Market Insights, Forecast to 2029
    Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 75
    SLE is the most common form of lupus and is also called lupus. It is a chronic, autoimmune disease with signs and symptoms that can last for six months or for many years. It can affect any part of the body, such as the skin, joints, and organs (LFA, 2012). SLE occurs when the immune system produces autoantibodies, which attack and destroy healthy tissues in the body rather than foreign infectious agents. These autoantibodies cause inflammation, pain, and damage. It is also known as a disease of ......
  • Global Systemic Lupus Erythematosus (Sle) Drugs Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 11-Jul-2023        Price: US 3260 Onwards        Pages: 130
    The Systemic Lupus Erythematosus (Sle) Drugs market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Systemic Lupus Erythematosus (Sle) Drugs industry, and breaks down according to the type, application, and consumption area of Systemic Lupus Erythematosus (Sle) Drugs. The report also introduces players in the industry from the per......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs